全国已确诊217例新型冠状病毒感染的肺炎病例

2020-01-20 央视新闻客户端 央视新闻客户端

湖北省武汉市等多个地区发生新型冠状病毒感染的肺炎疫情。截至1月20日18时,境内累计报告新型冠状病毒感染的肺炎病例224例,其中确诊病例217例(武汉市198例,北京市5例,广东省14例);疑似病例7例(四川省2例,云南省1例,上海市2例,广西壮族自治区1例,山东省1例)。日本通报确诊病例1例,泰国通报确诊病例2例,韩国通报确诊病例1例。(文章来源:央视新闻客户端)(原标题:全国已确诊217例新型

湖北省武汉市等多个地区发生新型冠状病毒感染的肺炎疫情。截至1月20日18时,境内累计报告新型冠状病毒感染的肺炎病例224例,其中确诊病例217例(武汉市198例,北京市5例,广东省14例);疑似病例7例(四川省2例,云南省1例,上海市2例,广西壮族自治区1例,山东省1例)。日本通报确诊病例1例,泰国通报确诊病例2例,韩国通报确诊病例1例。
(文章来源:央视新闻客户端)

(原标题:全国已确诊217例新型冠状病毒感染的肺炎病例)

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636122, encodeId=ce371636122da, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Wed Nov 11 02:14:00 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840148, encodeId=6905184014886, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Sat Feb 29 03:14:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651293, encodeId=bf28165129368, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Tue Jul 14 05:14:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085489, encodeId=67842085489e9, content=<a href='/topic/show?id=dd7a8218503' target=_blank style='color:#2F92EE;'>#肺炎病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82185, encryptionId=dd7a8218503, topicName=肺炎病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Fri Dec 11 18:14:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378371, encodeId=efd83e837179, content=每天都要关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 21 13:17:20 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636122, encodeId=ce371636122da, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Wed Nov 11 02:14:00 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840148, encodeId=6905184014886, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Sat Feb 29 03:14:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651293, encodeId=bf28165129368, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Tue Jul 14 05:14:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085489, encodeId=67842085489e9, content=<a href='/topic/show?id=dd7a8218503' target=_blank style='color:#2F92EE;'>#肺炎病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82185, encryptionId=dd7a8218503, topicName=肺炎病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Fri Dec 11 18:14:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378371, encodeId=efd83e837179, content=每天都要关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 21 13:17:20 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636122, encodeId=ce371636122da, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Wed Nov 11 02:14:00 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840148, encodeId=6905184014886, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Sat Feb 29 03:14:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651293, encodeId=bf28165129368, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Tue Jul 14 05:14:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085489, encodeId=67842085489e9, content=<a href='/topic/show?id=dd7a8218503' target=_blank style='color:#2F92EE;'>#肺炎病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82185, encryptionId=dd7a8218503, topicName=肺炎病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Fri Dec 11 18:14:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378371, encodeId=efd83e837179, content=每天都要关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 21 13:17:20 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636122, encodeId=ce371636122da, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Wed Nov 11 02:14:00 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840148, encodeId=6905184014886, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Sat Feb 29 03:14:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651293, encodeId=bf28165129368, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Tue Jul 14 05:14:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085489, encodeId=67842085489e9, content=<a href='/topic/show?id=dd7a8218503' target=_blank style='color:#2F92EE;'>#肺炎病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82185, encryptionId=dd7a8218503, topicName=肺炎病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Fri Dec 11 18:14:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378371, encodeId=efd83e837179, content=每天都要关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 21 13:17:20 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636122, encodeId=ce371636122da, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Wed Nov 11 02:14:00 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840148, encodeId=6905184014886, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Sat Feb 29 03:14:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651293, encodeId=bf28165129368, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Tue Jul 14 05:14:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085489, encodeId=67842085489e9, content=<a href='/topic/show?id=dd7a8218503' target=_blank style='color:#2F92EE;'>#肺炎病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82185, encryptionId=dd7a8218503, topicName=肺炎病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Fri Dec 11 18:14:00 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378371, encodeId=efd83e837179, content=每天都要关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Jan 21 13:17:20 CST 2020, time=2020-01-21, status=1, ipAttribution=)]
    2020-01-21 lovetcm

    每天都要关注

    0

相关资讯

Nat Commun:新多肽抑制剂可阻断新型冠状病毒繁衍

复旦大学基础医学院医学分子病毒学教育部/卫生部重点实验室姜世勃教授课题组经1年多攻关,发现了一种可拮抗中东呼吸系统综合征冠状病毒的高效多肽抑制剂,该成果对进一步研究该病毒的入侵机制和研发防治该病毒的特效药物具有重大意义。相关研究论文日前发表在国际杂志《自然·通讯》上。 中东呼吸系统综合征(MERS,简称为玛斯)是由一种新型冠状病毒引起的新发传染病。玛斯2012年6月首现于沙特,目前确诊的玛斯病例

新型冠状病毒感染者首现阿曼

阿曼卫生部30日宣布,该国日前出现首例中东呼吸系统综合征冠状病毒(新型冠状病毒)感染病例。 阿曼卫生部在声明中说,一名当地男子29日被确诊感染这种病毒,他此前患有糖尿病和高血压等慢性病,从未离开阿曼去过其他国家。这名患者目前已被送入当地医院救治,阿曼卫生部门正密切关注新型冠状病毒的传播,加强医学监测,启动相关防控措施。 声明指出,新型冠状病毒感染病例在全世界

WHO:MERS疫情尚未进入紧急状态

世界卫生组织14日发布声明说,该机构针对全球新型冠状病毒(中东呼吸系统综合征冠状病毒,MERS)疫情召开了紧急委员会会议。该委员会认为,尚未有证据表明这种病毒能在人际间持续传播,因此目前仍不构成“国际关注的公共卫生紧急事件”。 世卫组织根据2007年生效的《国际卫生条例》,已先后举行五次研讨新型冠状病毒疫情的紧急委员会远程会议。在综合评估各方信息后,与会委员认为,就新型冠状病毒对全球公共卫生

科威特出现第一例新型冠状病毒感染病例

科威特卫生部13日证实,一名47岁的科威特公民被确诊感染了新型冠状病毒。 科威特卫生部抗传染病处负责人萨利赫在当天举行的记者会上说,被确诊为感染新型冠状病毒的患者已经从普通医院转到科威特传染病医院接受隔离治疗。 萨利赫说,自从邻国出现新型冠状病毒以后,科威特卫生部门就制订了严格的应对措施,以便在科威特国内出现新型冠状病毒感染病例后采取及时有效的应对措施。 中东呼吸系统综合征冠状病毒(新型冠状

习近平对新型冠状病毒感染的肺炎疫情作出重要指示

新华社北京1月20日电 近期,湖北省武汉市等多个地区发生新型冠状病毒感染的肺炎疫情。截至1月20日18时,境内累计报告新型冠状病毒感染的肺炎病例224例,其中确诊病例217例(武汉市198例,北京市5例,广东省14例);疑似病例7例(四川省2例,云南省1例,上海市2例,广西壮族自治区1例,山东省1例)。日本通报确诊病例1例,泰国通报确诊病例2例,韩国通报确诊病例1例。疫情发生后,党中央、国务院高度

世卫组织:中国已分享新型冠状病毒基因序列信息

世界卫生组织12日宣布,已收到中国分享的从武汉不明原因病毒性肺炎病例中检测到的新型冠状病毒基因序列信息。世卫组织还表示,不建议对中国实施任何旅行或贸易限制。